Tarsus Pharmaceuticals, Inc. short interest in 2026
In 2026, Tarsus Pharmaceuticals, Inc.'s disclosed short interest ran from 12.64% of shares outstanding on 15 Jan 2026 to 13.96% on 15 Sep 2026, a change of +1.32 percentage points. The year's high was 13.96% on 15 Sep 2026 and its low 10.74% on 15 Apr 2026, averaging 12.56% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.24 days on 15 Apr 2026. Full history: Tarsus Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 12.64% (15 Jan 2026)
- End of year
- 13.96% (15 Sep 2026)
- Change
- +1.32 pp
- High
- 13.96% (15 Sep 2026)
- Low
- 10.74% (15 Apr 2026)
- Average
- 12.56%
- Highest days to cover
- 13.24 (15 Apr 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 12.64% | 10.24 | |
| 30 Jan 2026 | 13.69% | 10.69 | |
| 13 Feb 2026 | 12.86% | 9.83 | |
| 27 Feb 2026 | 12.55% | 6.81 | 10-K filed, results (8-K) |
| 13 Mar 2026 | 11.83% | 10.14 | |
| 31 Mar 2026 | 10.78% | 8.99 | |
| 15 Apr 2026 | 10.74% | 13.24 | |
| 30 Apr 2026 | 11.35% | 7.50 | |
| 15 May 2026 | 11.40% | 5.73 | 10-Q filed, results (8-K) |
| 29 May 2026 | 11.91% | 7.43 | |
| 15 Jun 2026 | 11.57% | 8.90 | |
| 30 Jun 2026 | 13.69% | 6.24 | |
| 15 Jul 2026 | 13.44% | 3.18 | |
| 31 Jul 2026 | 13.71% | 6.58 | |
| 14 Aug 2026 | 13.67% | 7.49 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 13.70% | 9.80 | |
| 15 Sep 2026 | 13.96% | 6.64 |
See also: Tarsus Pharmaceuticals, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.